ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Evotec, a German contract drug discovery firm, has made a $68 million cash offer to acquire Cyprotex. The 17-year-old firm with headquarters in England conducts preclinical contract research in drug metabolism, pharmacokinetics, and toxicology. It employs 136 people across sites in Watertown, Mass.; Kalamazoo, Mich.; and Macclesfield and Alderley Park, England. The companies expect to complete the transaction before the end of the year.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X